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Abstract
In human airways diseases, including cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), host defense is
compromised and airways inflammation and infection often result. Mucus clearance and trapping of inhaled pathogens
constitute key elements of host defense. Clearance rates are governed by mucus viscous and elastic moduli at physiological
driving frequencies, whereas transport of trapped pathogens in mucus layers is governed by diffusivity. There is a clear need
for simple and effective clinical biomarkers of airways disease that correlate with these properties. We tested the hypothesis
that mucus solids concentration, indexed as weight percent solids (wt%), is such a biomarker. Passive microbead rheology
was employed to determine both diffusive and viscoelastic properties of mucus harvested from human bronchial epithelial
(HBE) cultures. Guided by sputum from healthy (1.5–2.5 wt%) and diseased (COPD, CF; 5 wt%) subjects, mucus samples were
generated in vitro to mimic in vivo physiology, including intermediate range wt% to represent disease progression. Analyses
of microbead datasets showed mucus diffusive properties and viscoelastic moduli scale robustly with wt%. Importantly,
prominent changes in both biophysical properties arose at ,4 wt%, consistent with a gel transition (from a more viscous-
dominated solution to a more elastic-dominated gel). These findings have significant implications for: (1) penetration of cilia
into the mucus layer and effectiveness of mucus transport; and (2) diffusion vs. immobilization of micro-scale particles
relevant to mucus barrier properties. These data provide compelling evidence for mucus solids concentration as a baseline
clinical biomarker of mucus barrier and clearance functions.
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Introduction
There has been a longstanding observation that mucus solids
concentration (% solids by weight including salts, denoted wt%) rises
with increasing severity of many lung diseases such as chronic
obstructive pulmonary disease (chronic bronchitis phenotype) and
cystic fibrosis (See Figure 1) [1–3]. The underlying causes of
increased mucus solids concentration are diverse, ranging from
depletion of the airway surface liquid due to genetic defects in ion
channels as in cystic fibrosis [4] to hypersecretion of mucins in
chronic obstructive pulmonary disorders [5], or a combination of
both. The consequences of mucus hyper-concentration for disease
pathogenesis appear to be reduced mucus clearance and a higher
incidence of lung infection [6,7]. Despite these correlations, an
understanding of the explicit biophysical and cell biologic roles for
increased mucus solids concentration in airways disease patho-
genesis has not been established.
The mucus layer provides host defense for airways by serving as
both a barrier to penetration of inhaled materials to the airway
epithelium and a vehicle for mechanical clearance. A simple fluid
cannot perform these host defense functions. Rather, the requisite
flow transport and diffusive properties of airway mucus are
attributed to the underlying polymeric backbone generated by the
high molecular weight secreted mucins, MUC5AC and MUC5B.
Mucins are negatively charged, glycosylated proteins that are
continuously synthesized and secreted to replenish the mucus
layer. Mucins also contain cysteine-rich domains, where no
glycosylation is present, which have hydrophobic properties [8–
10]. To avoid contact with water, the hydrophobic portions of the
molecules form dynamic, physical mucin-mucin interactions that
behave as effective crosslinks [11]. Further mucin-mucin interac-
tions result from di-sulfide bonds [12]. The net result of the
interactions of mucins with other mucins, as well as other
biomolecules present in the mucus layer, is a viscoelastic material
that is responsive to a wide frequency range of forcing (breathing,
cilia, cough) and to trapped particles whose diffusive paths are
controlled by the thermal fluctuations of the mucus molecular
network.
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The viscoelastic properties of mucus are governed by two
frequency-dependent functions: the viscous and the elastic moduli.
The relative magnitude of these biophysical functions is highly
dependent on the concentration of mucins, and on the distribution
of distinct mucin macromolecules. Airway mucus and intestinal
mucus, for example, have very different mucin macromolecular
distributions. Furthermore, measurable concentrations of DNA
and actin macromolecules in airway mucus and sputum are well
known in cystic fibrosis and other airways disease, which can
confound the role of mucins in biophysical properties [13,14].
Consequently, the efficiency of mucus clearance (the volume flow
rate for a given forcing mechanism) depends on the role and
dependence of mucus solids concentration in the interplay
between viscous and elastic moduli at frequencies relevant to
mucus clearance mechanisms. The three main force clearance
mechanisms are: 1) cilia beat-dependent clearance (10–15 Hz); 2)
the gas-liquid pumping clearance mediated by tidal breathing
(,0.1 Hz) [15] and 3) cough (a broad frequency spectrum of
turbulent air drag). Thus, an assessment of a subject’s mucus
clearance efficiency and the change in efficiency with disease
requires the characterization of mucus viscoelastic properties
across a broad range of forcing frequency. Likewise, the diffusivity
of mucus, relevant for its barrier properties, is far more complex
than that of a viscous fluid, requiring the same level of frequency-
dependent information as flow transport (details are given below).
We tested the hypothesis that a simple measure of mucus,
concentration (wt%) of solids, would serve as a surrogate for the
complex biophysics and potentially correlate with both functions
of airway mucus: diffusivity and viscoelasticity. First, we measured
mucus solids concentration (wt%) from sputum collected from
subjects in our pulmonary clinic and our clinical trial databases;
these data establish reference ranges for mucus concentration in
health and disease. Second, we used mucus derived from human
bronchial epithelial (HBE) cell cultures as a source that could be
tuned to mimic concentrations identified in-vivo from subject popula-
tions. Third, we implemented microrheological particle-tracking
techniques [16,17] in microliter volumes for each wt% mucus,
using 1 mm particles to approximate the scale of bacteria and
drug-delivery particles. This technique both circumvents the
volume constraints of airway mucus samples and yields informa-
tion over a range of physiological frequencies. Fourth, analytical
techniques of the datasets provided a comprehensive assessment of
barrier (diffusivity) and transport (viscoelasticity) functions of HBE
mucus versus concentration (wt%). We then investigated the
dependence of both diffusive and viscoelastic properties on wt% of
solids, while also searching for potential signatures of a qualitative
transition in either property that could signal a trigger point for
disease progression. Our results indicate that both clearance and
barrier functions of mucus scale with mucus solids wt%, providing
a theoretical and practical basis for the utility of mucus solids
concentration as a clinically effective marker for phenotyping
subjects with airway disease and for outcomes of clinical trials.
Methods
Selection of Mucus Model System
The utility of HBE cell culture mucus has been previously
demonstrated as both a biochemical and biophysical foundational
baseline of normal and pathological pulmonary mucus [18–22].
Various biochemical techniques are available, including high-
speed density centrifugation, mass spectrometry, combination high
pressure liquid chromatography with multi-angle light scattering
and refractometry, immunohistochemistry and immunobloting, as
well as mass spectrometry. These techniques afford either direct
measurements or strong inferences of the biophysical properties of
airway mucins such as molecular weight, radius of gyration, and
transitions versus concentration into mucin entanglement and
reptation regimes [23–26]. Further, it was been previously
demonstrated that by eluting dilute mucus through columns of
differing porosity, in the above mentioned HPLC/light scattering
refractometry apparatus, that the % solids make up of HBE cell
culture mucus is roughly 1% salt, with the remainder of the %
solids divided nearly evenly between mucins and proteins [19].
Sputum Collection
Sputum was collected from subjects either by spontaneous
expectoration or via sputum induction for different protocols. All
studies were approved by the UNC Institutional Review Board
and informed consent obtained from all subjects. Normal subjects
were induced with hypertonic saline for sputum collection; CF and
COPD subjects produced both spontaneous sputa as well as
receiving induction. The CF and COPD sputa spontaneously
expectorated were collected and stored in sterile cups on ice until
delivered to the core laboratory. Induced sputum was collected
from normal volunteers, CF, and COPD subjects via induction as
previously described [20,27]. In brief, the subjects were given
nebulized albuterol followed by nebulized hypertonic saline at
increasing doses of 3%, 4%, and 5% until able to produce a
sample. All subjects performed throat clearance and nasal
clearance prior to producing a sample. If an adequate sample
was obtained at the lower doses of hypertonic saline, they did not
progress to a higher solids concentration. The sputum samples
were kept on ice until delivered to the core laboratory, usually
within 30 minutes. Samples were collected in accordance with
protocols # 02-1305, 05-2876, and 07-1178, approved by the
Office of Human Research Ethics at The University of North
Carolina at Chapel Hill. Written consent was obtained from all
study participants.
Weight % Solids Measurements
The solids concentration of mucus was measured by aliquoting
between 100 and 200 mL of mucus or sputum on a pre-weighted
piece of foil and recording the final mass of the sample and foil.
The sample was then placed in an 80uC oven overnight. The final
mass of the dried foil and sample was recorded and solids wt%
calculated [18]. For in vivo sputum samples, percent solids (wt%)
Figure 1. Concentration (wt% solids including salts) of sputum
for normal, COPD, and cystic fibrosis samples. The data yields: for
normal sputum, 1.760.56 wt% from 17 samples; for COPD sputum,
3.762.3 wt% from 47 samples; and for cystic fibrosis, 7.0%62.3 wt%
from 21 samples. The red lines on the figure at 1.5% and 5% show the
range of HBE mucus solids concentrations assayed in this study.
doi:10.1371/journal.pone.0087681.g001
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were assessed by measurement of pre- and post-desiccation
weights of selected sputum plugs (200–500 mg) [28].
Preparation of Mucus Samples and Biochemical
Characterization
Mucus was harvested from primary human bronchial epithelial
(HBE) cell cultures as previously described [18,19,21]. Briefly,
excess surgical tissue was procured by the UNC Tissue Core
Facility. Normal human bronchial epithelial cells were cultured on
a 0.4 mm pore-sized Millicell (Millipore, Billerica, MA) coated
with collagen and maintained in air-liquid interface media (UNC
Tissue Core) as described in [29]. Over a period of 6 weeks,
confluent cultures developed cilia, generated and established a
periciliary liquid (PCL) layer surrounding the cilia, a mucus layer,
and the HBE culture transported mucus. Washings from .100
cultures were pooled and then concentrated against Spectra/Gel
to the desired wt%. Concentrated mucus was dialyzed against PBS
to insure isotonicity as previously described [18,21].
Diffusive Microbead Measurements
We selected 1 mm polystyrene particles with carboxyl surface
chemistry for use in our assays. This particle size is substantially
larger than the length scales of the mucin mesh network
[18,30,31]. The carboxyl functionalization rather than an amine
surface chemistry was chosen as previous studies have shown that
amine treated beads have impaired diffusion in sputum [32]. PEG
surface chemistries, which enhance the diffusion of smaller
particles (200 nm and smaller) [31,33] in mucus have little effect
on the diffusivity of larger (500 nm) particles [33]. These
considerations of particle size and surface chemistry imply that
the diffusive noise spectrum of 1 mm beads faithfully represents the
bulk linear viscoelasticity of the sample.
We note that bead surface treatment as described above is
designed to screen the binding affinities that mucins and associated
macromolecules in mucus have with certain pathogens and
microbes. One must screen these affinities so that the particle
fluctuations that are measured are as faithful as possible to the
inherent fluctuations of the mucus sample, which are then
transformed to viscoelastic moduli by the fluctuation-dissipation
relationship of complex fluids. This transformation is described in
the Methods sub-section,
Viscoelastic Transport Characterization
Our sample chamber consisted of a slide and coverslip
separated by a double layer of paraffin with a ,1 cm disc was
cut out of the to create a space for 5 mL of mucus to be loaded.
Once loaded, mucus samples were imaged by transmitted light,
and the motion of diffusing beads was recorded at 60 frames per
second with a high- speed video camera (Pulnix; JAI, CA). This
frame rate and exposure time were chosen to minimize static and
dynamic particle tracking error [34]. Bead position was deter-
mined using Video Spot Tracker (Center for Computer Integrated
Systems for Microscopy and Manipulation; (http://cismm.cs.unc.
edu/downloads/). Between 56 and 178 particles were tracked over
1800 frames at each mucus solids wt%.
Mean Squared Displacement (MSD) and Auto Correlation
Function (ACF) statistics of individual particles and
ensembles
Time series of particle positions, x(t),y(t)½  were obtained from
the Video Spot Tracker software, typical time series are shown in
Figure 2A. Using individual paths (i.e., time positions per particle),
the mean squared displacements, Dr2 tð Þ , were calculated as
follows,




x tiztð Þ{x tið Þð Þ2z y tiztð Þ{y tið Þð Þ2
h i
, ð1Þ
where t is the time lag and the integer N is the total number of
frames in a given image stream, which is 1800 for all single particle
datasets. The smallest lag is the reciprocal camera frame rate,
t~1=60 s, while the largest possible lag is t~1800=60~30 s.
However, statistical significance and independence of data points
each limit meaningful plots of MSD to tƒ16 s [34]. The
ensemble-averaged MSD, SDr2 tð ÞT , was calculated as,




Dr2p tð Þ, ð2Þ
where Np is the total number of particles tracked for a given mucus
solids wt%.
We computed the individual auto correlation function (iACF)
by averaging over the x and y coordinate ACFs (Figure 3). For
example, the xACF (rx tð Þ) corresponds to correlations in step sizes




i~1 x tiz1ztð Þ{x tiztð Þ{Dx
 
x tiz1ð Þ{x tið Þ{Dx
  
PN{t
i~1 x tiz1ð Þ{x tið Þ{Dx
 2h i , ð3Þ
where Dx is the average of all the x-increments. With the iACF
given by r tð Þ~ 1
2
rx tð Þzry tð Þð Þ, the ensemble averaged ACF is




rp tð Þ: We note that since time increments
were uniform, our ACF is easily scaled to make contact with the
velocity autocorrelation function that is routinely reported, cf.
[35].
Diffusive Transport Characterization: Fitting of MSD
paths to fractional Brownian motion (fBm)
For all mucus solids concentrations and over the time scales
(30 s) of each dataset, we found that the single particle and
ensemble MSD data were remarkably well approximated by a
uniform power law, as shown in Figure 2 and, therefore, consistent
with a scaling of the form,
SDr2 tð ÞT~DfBmta: ð4Þ
The notation used for the pre-factor, DfBm, in particular the
subscript fBm, stands for fractional Brownian motion, cf. [35]. For all
particle path data in mucus, we found 0vav1, i.e., the particle
obeyed uniform sub-diffusive scaling with a consistent exponent a
over the entire experimental timescale. Values for DfBm and a
were obtained through standard statistical fitting to linear
functions in log-log plots, ln Dr2 tð Þ
 
vs ln t½  , for tƒ3 s. These
fittings were for single particle displacement data, as opposed to
the ensemble average (Figure 4). The reported values of a and
DfBm per mucus solids concentration consisted of the mean and
spread over all particle paths versus solids wt%.
ð3Þ
Concentration-Dependent Airway Mucus Rheology
PLOS ONE | www.plosone.org 3 February 2014 | Volume 9 | Issue 2 | e87681
Viscoelastic Transport Characterization: Transforming
MSD statistics to viscoelastic moduli over a broad
frequency range
We follow Mason’s protocol [16] to approximate the viscoelastic
complex modulus, G vð Þ , versus frequency, v (Figure 5). Using
ensemble MSD values, SDr2 tð ÞT , the complex modulus is given
by,
G vð Þ~ 2kBT
3paiv= Dr2 tð Þf g , ð5Þ
Figure 2. Diffusivity properties of HBE mucus. A) Particle trajectories of 1 mm diameter particles for four concentrations over 30 s. B) Ensemble-
averaged MSD versus lag time for different mucus solids concentrations. The dashed line represents a viscous fluid; any smaller slope indicates sub-
diffusive scaling. C) Individual or path-wise MSD (iMSD) for particles embedded in mucus samples color-coded by solids concentration, for 1.5, 2.0, 3.0
wt%. D) iMSD for particles embedded in mucus samples color-coded by solids concentration, for 3.0, 4.0, 5.0 wt%. Note the vertical scale disparity with
Figure 2C.
doi:10.1371/journal.pone.0087681.g002
Figure 3. Autocorrelation function data of diffusive particle in mucus. A) Typical autocorrelation function (ACF) for a bead diffusing in
mucus with 2.5 wt% solids. B) Individual, ensemble averaged and theoretical ACF for 2.5 wt% solids mucus. The equation for the theoretical ACF is
given in the Materials and Methods section, from which the value of a~0:64 is obtained from Figure 3A. This plot is for the ACF in the x-coordinate,
the ACF in the y-coordinate looks similar.
doi:10.1371/journal.pone.0087681.g003
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where a~0:5 mm is the particle radius and = :f g denotes the
Fourier transform. The Fourier transform is approximated by:
iv= Dr2 tð Þ
 
&Dr2 1=vð ÞC 1za vð Þ½ i{a vð Þ: ð6Þ
Here a vð Þ~dln Dr




is the local logarithmic slope of
SDr2 tð ÞT at the frequency v~1=t and C :½  is the Gamma
function. This approximation is optimal when the MSD is locally
(in lag-time) well-approximated by a power law, which in our data
is satisfied not only locally but globally.
Determining mucus gel-point
Potential signatures of qualitative transitions in viscoelastic and
diffusive biophysical properties from these microbead rheology
tools were also sought. The protocol proposed by Larsen and Furst
[36] was employed to detect a signature of a sol-gel transition from
the comprehensive MSD data as a function of mucus wt%. The
point at which this transition occurs is known as the gel point. In
the context of 1 mm particles, the gel point was defined as the wt%
G00 vð ÞwG0 vð Þ at which mucus underwent a change from a
viscous-dominated sol (fluid), for which for all v, to an elastic-
dominated gel, for which for all frequencies v. The Larsen-Furst
protocol requires scaling each wt% MSD curve onto a master
MSD curve by scaling the axes by factors a (horizontal) and b
(vertical). The scaled MSD figures versus wt%, therefore, have
axes bSDr2 tð ÞT and at, as in [36] and Figure 6. The gel point (GP)
is defined as the solids concentration at which the logarithmic
slope, or power law, of the shifted master curve ‘‘breaks’’ from one
slope below GP to another above GP [36]. Note that these metrics
are based on the ensemble MSD scaling behavior versus lag time
across multiple samples, rather than the macrorheology standard
based on a comparison of G0 vð Þ and G00 vð Þ across a frequency
spectrum, which require transforms of the MSD data.
Results
Mucus Solids Concentration (wt%)
Figure 1 shows measured solids concentration (wt%) of sputum
for normal, COPD, and cystic fibrosis samples. The wt% for
normal subjects (17 samples from 17 individual patients ranging in
age from 20–44, with an average age of 26.6 years) has a mean of
1.7% with a relatively small standard deviation (0.56%). The wt%
from 28 COPD subjects (47 total samples from patients ranging in
age between 52 and 70, average age 60.5 years) were ,26higher
(3.5%) with a broader range (62.3%). Sputum wt% from 14 CF
subjects (21 total samples from patients ranging in age from 24 to
48 years, average 34.8) were ,46 higher (7.0%) than normal
sputum, with a variability similar to COPD (62.3%).
Diffusive Transport Characterization
Figure 2 provides a qualitative description of diffusive properties
of HBE mucus as a function of solids wt%. Figure 2A shows
representative trajectories of 1 mm particles in 1.5, 3.0, 4.0 and 5.0
wt% mucus. Figure 2B describes the calculated ensemble averaged
mean squared displacements (MSDs) for all the mucus solids
concentrations investigated, with a dashed line of slope 1 that
Figure 4. Scaling of the MSD versus mucus solids concentration, where SDr2 tð ÞT~DfBmta. A) Power law exponent. Squares represent the
averaged values of a and the vertical bands represent its range over all particle paths. The goodness of fit metric for the linear relationship is
R2~0:98. B) Scaling of the MSD pre-factor, DfBm , with goodness of fit R
2~0:96. C) Rough estimates of mean passage times of 1 micron particles
through a 25 micron mucus layer versus wt% solids, based on scaling behavior from Figures 4A&B.
doi:10.1371/journal.pone.0087681.g004
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corresponds to diffusion in a simple viscous fluid. Figures 2C–D
show individual time-averaged MSDs. These data reveal an
obvious trend toward smaller step sizes as mucus solids concen-
tration increases.
While qualitatively noteworthy, these analyses fail to provide
statistically significant data that allow for a meaningful character-
ization of mucus diffusive properties versus wt% of solids. We,
therefore, introduced quantitative metrics based upon fitting of
individual particle MSD data (Figure 2 C–D) to a fractional
Brownian motion (fBm) sub-diffusive law, which relates the
squared displacement, Dr2 , to the lag-time, t, by a two-parameter
function given by Eqn. (4).
The use of fBm [37] followed from three basic observations: 1)
the increments of the path data were Gaussian; 2) the variance of
these increments was stationary over time; and 3) the autocorre-
lation structure among increments (Figure 3) fitted remarkably
well to the theoretical structure of fBm. A similar argument was
used in modeling the motion of fluorescently labeled bacterial
chromosomal loci in cytoplasm [35], and fBm as a model can be
supported by other statistical techniques [38,39]. Note that for
normal diffusion (simple Brownian motion) of a particle of radius a
in a fluid of viscosity, g, the MSD exponent is a~1 and the pre-
factor, DfBm , reduces to the diffusion coefficient D~kBT= 6pagð Þ
. Therefore, any information pertinent to particle size and fluid
viscosity is included in the pre-factor. For sub-diffusion, and
fractional Brownian motion in particular, little is known about the
physical basis for the pre-factor, and it has therefore been
relegated to a secondary feature of fBm in the literature. We
found, however, that both fBm parameters correlated remarkably
well with mucus wt%.
The first striking result of Figure 4A is the linear scaling
behavior of the power law exponent versus mucus solids
concentration:
a&{0:17 wt%z1:1, for 1:5ƒwt%ƒ5, ð7Þ
with a very high confidence level, R2~0:98. The second feature of
note in Figure 4A is associated with the spread in the fitting (error
bars), which was relatively low at 1.5 and 2 wt%, grew at 3 wt%,
grew again at 4 wt%, but then dropped significantly at 5 wt%. This
feature, a sharp maximum in the spread among individual particle
paths at a fixed wt%, is suggestive of a transition in the
microstructure of mucus. At 4 wt%, there were many more ‘‘fast’’
and ‘‘slow’’ particle outliers relative to the mean. Yet at 5 wt%, not
only was the behavior more strongly sub-diffusive (a drop in a) but
there were very few outliers, with all particles essentially
immobilized. This behavior is consistent with a sol-gel transition.
Similar to our results, a spread of MSD data was recently observed
in respiratory mucus samples [40] and suggested as an indicator of
heterogeneity in pore size in the mucus microstructural network.
As indicated in Figure 4B, we found a robust trend in the pre-
factor DfBm versus mucus solids concentration, in this case with an
exponential form:
Figure 5. Frequency Dependent viscoelastic properties of mucus. A) Frequency-dependent complex viscosity g vð Þj j versus frequency v for
different mucus solids concentrations. B) The slope of the power law, g vð Þj j*v{s, is indicated for each wt% solids, both numerically and with a rise
vs. run plot. C) Storage, G0 vð Þ, and Loss, G00 vð Þ, moduli vs. frequency for mucus with 1.5 to 3.0 wt% solids. D), G0 vð Þand G00 vð Þ vs. frequency for
mucus with 3.0 to 5.0 wt% solids.
doi:10.1371/journal.pone.0087681.g005
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DfBm&1:6 exp {1:5|wt%ð Þ, for 1:5ƒwt%ƒ5, ð8Þ
and once again with a high R2 value of 0.96.
The fittings given by Eqns. (7)–(8) have immediate implications
for the expected particle passage time, denoted STT , through a
mucus layer of thickness, L. While first passage time properties are
not understood for general subdiffusive processes, the self-
similarity property of fBm allows us to compute reasonable
order-of-magnitude estimates for our physical processes. Let
STa 1ð ÞT denote the mean passage time of fBm to exit from the
interval 1,1½  starting from the origin. It follows thatSTa Lð ÞT, the
mean exit time from the interval ,L½ , is
STa Lð ÞT~ L2=Dfbm
 1=a
|STa 1ð ÞT [41]. There are, as yet, no
analytical results for determining STa 1ð ÞT, but numerical evidence
reveals that this is order 1 for the values of a we are interested in
here. In this manner, an estimate for the mean passage times of
1 micron diameter particles through a 25 micron layer was
calculated and graphed in Figure 4C. The graph reveals a
dramatic disparity in mean passage times through a nominal
airway mucus layer between 1.5 wt% and 5 wt% mucus, i.e., from
minutes at 1.5 wt% to complete immobilization at 5 wt%. We
caution that these estimates are crude indicators of passage times
versus mucus solids concentration prior to full-scale direct
numerical simulations, but the essential conclusion is clear and
compelling.
Viscoelastic Properties
The viscoelastic properties of HBE mucus were calculated from
the MSD statistics, following the protocol proposed by Mason
[16]. Figure 5A shows the amplitude of the frequency-dependent
complex viscosity g vð Þj j for 1.5, 2.0, 2.5, 3.0, 4.0, 5.0 wt%
mucus. The uniform power law behavior of MSD versus lag time,
illustrated in Figure 2B, was recapitulated as a uniform power law
in the complex viscosity in frequency space, g vð Þj j*v{s, where
the exponent s decays with decreasing solids concentration
(Figure 5A). However, in this case there was not a clear functional
form of the frequency-space exponent s versus wt%, as shown in
Figure 5B.
The real and imaginary parts of the complex viscosity carry
detailed information about the loss (viscous) modulus, G00 vð Þ, and
storage (elastic) modulus, G0 vð Þ, at each frequency, where
g vð Þ~G vð Þ=v and G vð Þ~G0 vð ÞziG00 vð Þ. Thus, since
Figure 5A did not inform the relative contributions of the storage
and loss moduli in the scaling behavior, G0 vð Þ and G00 vð Þ were
plotted separately for each wt% in Figures 5C–D. The graphs are
color-coded and font-specified by wt%, with G0 vð Þ denoted by
empty symbols and G00 vð Þ denoted by filled symbols. Several
striking results are conveyed by Figures 5C–D.
For example, below 3.0 wt%, the loss modulus, G00 vð Þ,
dominated the storage modulus, G0 vð Þ, uniformly across all
frequencies, implying low wt% mucus is a viscoelastic solution, or
sol, throughout this frequency range (Figure 5C). At 3.0 wt%, the
curves of G0 vð Þ and G00 vð Þ approach each other over the full
frequency range.
At 4.0 wt%, the elastic and viscous moduli were almost equal
over a frequency range between 0.1 and 10 Hz, suggesting the
onset of a transition from solution-like to gel-like behavior. Over the
remaining frequency range, the gap between the larger viscous
and lower storage modulus was significantly less than the lower
wt% data, again suggestive of the onset of a transition. At 5.0 wt%,
the elastic modulus, G0 vð Þ, dominated the viscous modulus,
G00 vð Þ, over the full frequency range implying high solids wt% mucus
is a viscoelastic gel at frequencies above 0.1 Hz.
As summarized in the Methods section, quantitative metrics
have been developed to characterize the sol-gel transition [36,42]
from passive microbead data. These MSD-based metrics were
implemented in Figure 6B, which revealed evidence for a mucus
sol-gel transition, or the point at which the elastic modulus (G0) is
larger in magnitude that the loss modulus (G00), just above 4.0 wt%.
Next, we related our experiments to reported viscoelastic studies
of mucus by extracting the dynamic moduli at the following
frequencies: 0.1 Hz to approximate the frequency of tidal
breathing; 10 Hz to approximate the frequency of the cilia beat
cycle; and, 1 Hz as an intermediate frequency added simply to
bridge the 0.1 and 10 Hz data. Figure 7 shows the storage
modulus G0 vð Þ (Figure 7A) and loss modulus G00 vð Þ (Figure 7B)
versus wt% for 0.1 Hz (black dots), 1 Hz (green squares), and
10 Hz (red x). The salient features of Figure 7 can be summarized
in the following points.
First, the capacity of mucus to store energy at a given frequency
of forcing is determined by the elastic (or storage) modulus,G0 vð Þ.
Vertical slices of data plotted in Figure 7A revealed that
G0 10 Hzð Þ&20G0 0:1 Hzð Þ for 1.5–4.0 wt%, i.e., the ratios of the
elastic moduli relevant to cilia and tidal breathing remain constant
over this range of wt%, even though the moduli are growing
significantly. Thus, across these solid concentrations, mucus is
tuned to preferentially store energy from cilia forcing (10 Hz) more
so than from tidal air drag (0.1 Hz). This observation implies that
mucociliary clearance exploits the elasticity of the mucus layer far
more so than air drag. Conversely, at disease-associated mucus
solids concentrations of ,5 wt%, the differentiation in energy
storage vs. frequency is diminished (the curves in Figure 7A are
converging).
Second, comparison of the change in storage modulus G0 from
the lowest (1.5 wt%) to the highest (5.0 wt%) mucus solids
Figure 6. Mucus Gel Point. A) Cartoon illustrating the mucus
network changes for increasing macromolecule (mucin) concentration.
The gel point (GP) is the point at which the strength of the chains
interacting with one another engenders the elastic moduli (G0) to be
comparable in magnitude to the viscous moduli (G00). B) Master curve of
ensemble-averaged MSDs. The solids concentration for sol-gel transi-
tion is obtained following [36], in this case breaking of the slope in the
master curve indicates the sol-gel transition occurs at a solids
concentration between 4.0 and 5.0 wt%.
doi:10.1371/journal.pone.0087681.g006
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concentration revealed that the storage modulus associated with
cilia forcing (10 Hz) increased by a factor of *103 , whereas the
storage modulus for tidal breathing (0.1 Hz) increased by a factor
of *104 . This dramatic increase in elastic modulus with wt%
suggests that at high wt% mucus is resistant to shear deformation
from all physiological phasic stresses, including single cilia, ciliary
carpets, and air drag. Importantly, this striking increase of G0 in
the 10–15 Hz range implies individual cilia would be unable to
generate sufficient force to penetrate the mucus layer.
Third, the energy dissipated by mucus at forcing frequency v is
measured by the viscous (or loss) modulus, G00 vð Þ. Vertical slices of
the data shown in Figure 7B revealed wt% dependent degrees of
differentiation at the 10 Hz of cilia relative to the 0.1 Hz of tidal
breathing. The differentiation was most significant in low wt%
mucus and decreased with increased wt%:
G00 10 Hzð Þ=G00 0:1 Hzð Þ*100 at 1.5 wt%, ,70 at 3.0 wt%, ,30
at 4.0 wt%, and ,5 at 5.0 wt%. These data imply that healthy wt%
mucus dissipates relatively less energy from tidal breathing than
from ciliary beating. This observation reinforces the implication
from the storage modulus results that cilia-dependent clearance is
tuned more to elasticity whereas clearance mediated tidal
breathing, i.e. ‘‘gas-liquid pumping’’, is tuned more to the viscous
component of healthy mucus. These differentiated moduli then
disappear at high solids wt% typical of advanced airways disease.
Fourth, the absolute changes in viscous moduli versus wt% were
strongly frequency dependent. G00 at cilia beat frequency rose by a
factor of 10–20 across the 1.5 to 5 wt% range, whereas at tidal
breathing frequency, G00 rose by a factor of ,600. These data
imply cilia-induced viscous stress dissipates 10–20 times more
rapidly in unhealthy vs. healthy wt% mucus, whereas tidal
breathing stress dissipates 100’s of times more rapidly in unhealthy
mucus. The implication is that the previously noted viscosity-
dominated emphasis of the tidal breathing (‘‘gas liquid pumping’’)
clearance mechanism at healthy wt% mucus is precipitously lost
with increased wt%.
Discussion
Abnormal mucus solids concentration, measured as wt% (solids),
has been associated with airways disease, but has not been
developed as a biomarker for lung disease because its pathophys-
iologic relevance has remained unclear. Recent evidence has
suggested that the high molecular weight airway mucins in mucus
form an interpenetrating mesh whose biophysical functions are
highly dependent on their solids concentration, i.e., their
hydration [22]. Using microrheological experimental approaches
and new analytic techniques, we have systematically characterized
the diffusive and viscoelastic properties of HBE mucus that relate
to its barrier function and transportability over normal (1.5–2 wt%)
and disease associated (.4 wt%) solids concentrations and
physiologically relevant frequency spectra.
With respect to the barrier properties of mucus, the fate of
inhaled particles was modeled from measurements of the diffusive
properties of particles in airway mucus. A particle size was selected
that was relevant to disease, i.e., 1 mm particles, mimicking
bacterial size. It is well known that the motion of microscopic
particles in complex liquids and soft gels is described by a mean-
squared-displacement that is sub-linear in time (called sub-
diffusive) [16,25,43–45]. However, predictive simulations of the
passage times of particles through mucus at varying solids
concentrations are only possible once accurate sub-diffusive laws
and best-fit parameters are determined, since there is no
theoretical basis (i.e., no analytical formula) for passage time
distributions of sub-diffusive stochastic processes. In this work, we
fitted fractional Brownian motion [35,37–39] to comprehensive
experimental data and demonstrated a remarkably robust fit and
scaling of the model parameters versus mucus solids wt% (Figure 4).
Consequently, we have identified an accurate sub-diffusive law
and found best-fit parameters for the ensemble particle path data
in each wt% mucus.
Figures 2 and 4 provide a robust characterization of the
diffusive properties of HBE mucus versus solids concentration that
demonstrate four critical points. First, at every fixed mucus solids
wt%, individual path and ensemble averaged MSD versus lag time
were linear on a log-log scale, indicating a uniform power law
behavior that was remarkably consistent with fractional Brownian
motion, Eqn. (4). Second, beyond exhibiting a power law scaling in
the MSD, path increments were Gaussian and the autocorrelation
function (ACF) exhibited remarkable agreement with the theoret-
ical form for fractional Brownian motion, (Eqn. (3) and Figure 3).
Third, the two data-inferred parameters that characterize
fractional Brownian motion, the power law exponent a and the
pre-factor DfBm , obeyed robust fits to a linear and an exponential
dependence on mucus wt%, Eqns. (7)–(8), respectively. Fourth,
both fBm parameters, a and DfBm , were decreasing functions of
mucus solids wt%, indicating sub-diffusivity was progressively
exaggerated as mucus solids concentration increased.
This scaling behavior of MSD translated to a rough estimate of
mean passage times for a 1 micron particle, the approximate size
of airway bacteria, through a 25 micron mucus layer as: hours at
Figure 7. Concentration dependent viscoelastic properties of mucus at key frequencies. A) Elastic (storage) modulus, G0 vð Þ, versus
mucus solids concentration for three representative frequencies (from cilia to tidal breathing). B) Viscous (loss) modulus, G00 vð Þ, versus mucus solids
concentration for three representative frequencies.
doi:10.1371/journal.pone.0087681.g007
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1.5 wt%; 1 day at 2.0 wt%; months at 2.5 wt%; a year at 3.0 wt%;
and, effectively complete immobilization at 4.0 wt% and above.
There was a signature just above 4.0 wt% indicating both a smaller
sub-diffusive exponent and a dramatic reduction in variability
across paths. Above 4.0 wt%, there were essentially no outliers,
implying complete immobilization of trapped micro-particles.
The data described in Figure 5 point to an explanation for this
observation. A clear transition from G00 vð Þ -dominated moduli (a
viscous-dominated solution) to G0 vð Þ -dominated moduli (an
elasticity-dominated gel) was observed at a critical mucus wt%
over the full frequency range. This behavior is the classical macro-
rheological signature of a sol-gel transition [42]. The gel point was
more accurately inferred by comparing the MSD statistics of
passive microbead data obtained from samples that were in both
the sol (or solution) and gel phases (Figure 6). These conditions are
easily observed in real time during observations of a gelation
process as discussed in [36].
We note the similarities between our findings on HBE cell
culture mucus versus wt% of solids with recent findings of
Georgiades et al. on purified gastrointestinal mucins versus mucin
concentration [23,26]. Namely, Georgiades et al. identify a
concentration-dependent, power law scaling in the viscosity of
purified mucin below a threshold concentration, followed by a
transition to a different power law scaling above a concentration
threshold. Thus, a key macroscopic metric (viscosity) of purified
gastrointestinal mucins strongly correlates with mucin concentra-
tion, marked by a qualitative transition at a critical concentration
that is associated with an entanglement transition and an
important role of reptation. We note the related work of Katz et
al. [46] where viscosity of CVM was shown to scale with
hydration, the work of Verdugo et al. [47] where the role of ion-
dependent swelling of mucus gels affects viscoelasticity. Our
studies are on HBE mucus, which not only contains mucins but
additional proteins that constitute the mucus network; our
qualitative transition at a critical wt% of solids is a gel transition
where a spectrum of viscous and elastic moduli switch relative
dominance. As a further point of comparison of these studies, the
low frequency viscosity of HBE cell culture mucus at any fixed
wt% solids is significantly higher than the viscosity of purified
mucins at a comparable mucin concentration. This underscores
the critical role of the additional proteins in mucus beyond pure
mucins in constituting the mucus network and biophysical
properties. Furthermore, this purified mucin vs. cell culture mucus
comparison points to additional studies necessary on cell culture
mucus vs. clinical mucus and sputum samples, to identify the
biophysical and viscoelastic impact of additional proteins, as well
as other biomolecules including actin and DNA [13,14].
Once we determined the gel point (GP) of HBE mucus to be
between 4 and 5 wt% (Figure 6), the physical basis for the
observations in the MSD shown in Figures 2 and 3 became
apparent (see descriptive model, Figure 6A). As described above,
mucus contains large hydrogel-forming mucins, which together
with other proteins form a mesh that provides mucus its
viscoelastic properties. At low wt% solids, the spatial structure of
the mucin network is relatively homogeneous at micron scales, i.e.,
all particles exhibit similar sub-diffusive behavior as indicated by
the relatively small error bars seen in Figure 4. Just below the wt%
of the GP, the network forms micro-domains that increase in
density as the GP is approached, i.e., the particle ensemble
experiences diverse microenvironments resulting in a larger spread
of the MSD power law. Above the GP, the gel domains dominate
the mucus network so that all particles experience highly confined
behavior with a reduction in the MSD power law, a, and pre-
factor, DfBm, and a reduction in the spread across the particles.
Our analysis should facilitate future studies to explore the
interactions of mucus solids concentration with a spectrum of
particle sizes and surface chemistry.
The measured decrease in micro-particle diffusivity, as a
function of increasing mucus wt% solids, may reflect an enhanced
mucus barrier function with disease. Indeed, this response could be
beneficial compensation to buffer the exposure to environmental
stressors associated with environment-induced airways disease.
However, it has been reported that bacteria deposited on high
wt% mucus favor biofilm formation, in part because of decreased
mobility of bacteria and diffusivity of auto-inducers from the point
of bacterial deposition [18].
Our data also provided insights into the relationships between
wt% solids, viscoelastic properties, and mucus transport. The
physical mechanisms and magnitudes of force application to
produce transport of mucus are quite different for each transport
mechanism. For example, force application by cilia requires rapid
(10 Hz) penetration of cilia into the mucus layer mesh and mesh
deformation. Gas liquid pumping requires that the force of airflow
be imparted to mucus by an interaction of air and the mesh
dependent ‘‘roughness’’ of the air-exposed face of the mucus layer.
Cough produces a more turbulent, high frequency form of air drag
on the mucus layer.
The present work (Figures 5–7), and previous studies in cystic
fibrosis sputum (both whole [24], and samples separated by low
speed centrifugation [48]), cervicovaginal mucus (CVM) [49],
sino-nasal mucus in patients with chronic sinusitis [50], and pig
gastrointestinal mucus (PGM) [51,52], demonstrate that single
frequency viscoelastic moduli are insufficient to draw inferences
about the efficacy of mucus transport mechanisms. The data
reveal that the viscous and elastic moduli of a given mucus sample
vary by orders of magnitude across the frequency spectra relevant
to each mode of mucus transport. Importantly, an even greater
variation is observed versus mucus solids wt%. Such widely varying
mucus solids concentrations require tools in place that detect the
physiologically relevant viscoelastic properties of a mucus sample
specific to each clearance mechanism.
A complete biophysical understanding of the contribution of
viscoelastic properties to the variation in mucus transport in
patients is not available. However, we note that a correlation
between concentrated, pathological mucus and decreased clear-
ance has been reported [1] and our data yields insights into the
mechanisms by which solids wt%-dependent changes in viscoelas-
tic properties may contribute to this correlation. For example,
Puchelle [53] demonstrated that when cilia beat against a viscosity
higher that 100 mPa?s, i.e., a viscosity 100 times that of water,
beat frequency decreased and mucus clearance slowed. More
recently, direct force measurements of individual airway cilia
revealed that cilia are tuned to beat against a 100 mPa?s fluid, but
begin to fail at higher viscosities [1]. Our results show that mucus
in excess of 2.5 wt% solids exhibits complex viscosities higher than
the 100 mPa?s threshold at frequencies characteristic of cilia
(10 Hz), providing key data linking increased mucus concentra-
tions to the observation of Puchelle et al. [53]. Our results further
predict reductions in mucus clearance efficiency with increased
mucus solids wt% across the entire physiological frequency force
spectrum, from the 0.1 Hz of tidal breathing to the 10 Hz of cilia
beat, determined on the basis of viscous and elastic modulus
transitions (Figure 5). Combining our results with previous studies,
we conclude that cilia dependent and gas liquid dependent mucus
clearance is significantly and progressively compromised at mucus
concentrations above 2.5 wt% solids.
Cough is the principal back-up mechanism for failed mucus
clearance, and our viscoelastic analyses also provide insight into
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the effectiveness of cough to offset concentration-dependent
inefficiencies in cilia and breathing-induced mucus transport.
For example, cilia have to penetrate the mucus layer for their force
to be transferred to the layer and induce transport. Under high
wt% solids conditions where cilia cannot transfer force to mucus,
the 20-fold increases in G00 10Hzð Þ and 100-fold increases in
G0 10Hzð Þ between healthy and unhealthy solids wt% mucus could
be temporarily reduced by the violent air drag associated with
cough. Sufficient forcing from cough has the potential to shear-
thin (lower G00) and soften (lower G0) mucus, affording cilia a brief
window to recapture their ability to penetrate the mucus layer
before the high solids wt% mucus gel recovers from the disruptions
induced by cough. Some airways diseases, e.g., in particular CF,
lead to continuous cough, presumably in part to generate more
efficient transport properties of mucus.
Another mechanism for compromised mucociliary clearance
(MCC) associated with pathological, high solids concentration
mucus has been recently identified, namely an increase in the
relative osmotic pressure of the mucus layer versus the gel-like
properties of a concentrated periciliary layer. The osmotic
pressures of each layer reflect the activities of the interpenetrating,
i.e., semi-dilute, mesh-like properties of their respective mucins.
Button et al. [22] demonstrated that the mucus and periciliary
layers must be in osmotic balance for efficient MCC. When the
osmotic pressure of the mucus layer exceeds that of the periciliary
layer, water is drawn from and collapses the periciliary layer,
compromising the normal cilia beat stroke.
By comparing the mucus layer’s osmotic modulus vs. periciliary
layer height data with the measured osmotic modulus of mucus vs.
wt% (data reported by Button et al., Figures 6 and S1 [22]), the
osmotic pressure of mucus began to exceed that of the periciliary
layer at a mucus concentration of ,5 wt% (a value approaching that
seen in CF mucus), causing a decrease in periciliary layer height. At
concentrations at and above 8.0 wt%, the periciliary layer was
completely collapsed, totally disabling MCC. These findings are
complementary to our results, which predict the onset and
progression of cilia and tidal breathing-induced mucus transport
at much lower mucus solids wt%, beginning between 2.5 and 3.0
wt%. Further, we found that a dramatic transition in mucus
viscoelasticity across all physiological frequencies arose at ,4.0
wt%, associated with a sol-gel transition (Figure 6). Thus, our data
predict a slowing of mucus transport due to abnormal viscoelastic
properties prior to complete osmotic collapse of the periciliary
layer and shutdown of mucociliary clearance. Indeed, slowing of
mucus transport has been observed in COPD subjects with mucus
solids wt% in the 2–4% range [54].
Collectively, our data suggest that the wt% solids of mucus will
serve a simple surrogate for the mucin concentrations that govern
the key viscoelastic properties of mucus relevant to flow/no-flow.
One question is whether wt% solids will perform well in sputum
from subjects with airways disease. In CF sputum, the uniquely
large amount of DNA and actin, with its intrinsic viscoelastic
properties in extracellular solutions, may confound the wt% solids
measurement, and likewise confound the source of potentially
dramatic changes in viscoelastic properties. Precise measures of the
wt%-dependent DNA effects on CF sputum biophysical properties
will be required to answer this question. Importantly, the presence
of inflammatory cells contributes negligibly to wt% over a wide
range of cell numbers, suggesting wt% will be useful in subjects
with several inflammatory airways diseases, e.g., both COPD and
CF. Indeed, wt% solids may be a particularly useful biomarker to
identify subsets of subjects with COPD that exhibit a chronic
bronchitic phenotype.
In summary, the significant conclusions of this study lie in the
robust scaling of both diffusive and viscoelastic properties of HBE
cell culture mucus versus wt% of solids, ranging from those
associated with normal sputum concentration to pathological
concentrations. Our analysis using fractional Brownian motion,
and in particular Eqns. (7) and (8), offers an efficient protocol to
access this information, and it provides compelling evidence that
the simple marker of mucus wt% solids is an indicator of the
diffusive and viscoelastic biophysical abnormalities of mucus
associated with disease. These findings point to wt% solids of
lung mucus as a candidate for a rational and easily applied clinical
biomarker of airways disease.
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